Elaine O'Hara
EVP, Chief Strategy Officer · NOVAVAX INC
Individual
- 2026
- Mar 9, 2026
- 3
Filings (90d)
0
Other insiders active in the same sector
No other insider has filed at Elaine O'Hara's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Joaquin Duato - $66.84M in JNJ purchases and sales in the last 12 months
- Eric Venker - $65.62M in ROIV purchases and sales in the last 12 months
- EcoR1 Capital, LLC - $65.00M in TRAX purchases and sales in the last 12 months
- Forbion Growth Opportunities Fund III Cooperatief U.A. - $64.80M in BRVE purchases and sales in the last 12 months
- RA CAPITAL MANAGEMENT, L.P. - $63.45M in SEPN purchases and sales in the last 12 months
- BVF PARTNERS L P - $62.96M in MLTX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Elaine O'Hara?
Elaine O'Hara is a corporate insider, tracked as EVP, Chief Strategy Officer of NOVAVAX INC (NVAX). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Elaine O'Hara last file a Form 4?
The most recent primary Form 4 on record is dated 9 March 2026, one of 3 filings going back to 2026.
